# Therapeutic Virtual Reality : Impact on the Management of Pain and Anxiety Related to Hematology Care (REVEH)

> **NCT03483194** · PHASE2,PHASE3 · COMPLETED · sponsor: **Weprom** · enrollment: 126 (actual)

## Conditions studied

- Hematologic Neoplasms

## Interventions

- **DEVICE:** Virtual Reality
- **DRUG:** Kalinox

## Key facts

- **NCT ID:** NCT03483194
- **Lead sponsor:** Weprom
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-09-06
- **Primary completion:** 2020-04-20
- **Final completion:** 2020-06-19
- **Target enrollment:** 126 (ACTUAL)
- **Last updated:** 2020-06-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03483194

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03483194, "Therapeutic Virtual Reality : Impact on the Management of Pain and Anxiety Related to Hematology Care (REVEH)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03483194. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*